Coupling between visual information and body sway in people with Parkinson’s disease
Objective: Investigate postural control performance and the coupling between visual information and body sway in people with Parkinson's disease (PD). Background: PD causes several changes…The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients
Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…Long-latency somatosensory evoked potentials of the subthalamic nucleus
Objective: This study aims to clarify the role of the STN, previously suggested as an integrative component in the control of the basal ganglia-thalamocortical circuit,…Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…EEG Spectral power changes prior to non-epileptic seizures: A pilot study
Objective: To assess possible EEG spectral power changes prior to psychogenic non-epileptic seizures (PNES) and identify whether a “positive marker” of PNES may exist. Background:…Loss of heart rate variability in ALS: Time and frequency domain assessment
Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up
Objective: To describe the number and reasons of the visits to the emergency room (ER) and the hospitalizations of Parkinson's disease (PD) patients for a…The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2
Objective: To study the state of lipid metabolism in PD patients with concomitant type 2 diabetes with different glucose tolerance and the influence of the…Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model
Objective: To prepare and evaluate the nanoherbaceutical formulation containing natural L-DOPA from Mucuna pruriens against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinson's disease (PD). Background: PD is…The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype
Objective: To evaluate the role of proprioceptive processing on the gait parameters of different subtypes of Parkinson's disease. Background: Two major subtypes are considered in…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.